WO2008133789A3 - Methods and compositions for targeting afap - Google Patents

Methods and compositions for targeting afap Download PDF

Info

Publication number
WO2008133789A3
WO2008133789A3 PCT/US2008/003686 US2008003686W WO2008133789A3 WO 2008133789 A3 WO2008133789 A3 WO 2008133789A3 US 2008003686 W US2008003686 W US 2008003686W WO 2008133789 A3 WO2008133789 A3 WO 2008133789A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
cancer
afap
targeting
Prior art date
Application number
PCT/US2008/003686
Other languages
French (fr)
Other versions
WO2008133789A4 (en
WO2008133789A2 (en
Inventor
Daniel C Flynn
Peter Gannett
Original Assignee
West Virginia University C O O
Daniel C Flynn
Peter Gannett
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Virginia University C O O, Daniel C Flynn, Peter Gannett filed Critical West Virginia University C O O
Priority to EP08779575A priority Critical patent/EP2136620A2/en
Publication of WO2008133789A2 publication Critical patent/WO2008133789A2/en
Publication of WO2008133789A3 publication Critical patent/WO2008133789A3/en
Publication of WO2008133789A4 publication Critical patent/WO2008133789A4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Embodiments of the invention are directed to methods and compositions for inhibiting activation of cSrc by human actin filament associated protein (AFAP). Libraries and methods of screening compositions for inhibitive activity are also provided. Also provided are methods of treating cancer. Cancer may be, for example, but is not limited to ovarian cancer, breast cancer, and gastrointestinal cancer. Also provided are methods of decreasing resistance to chemotherapy.
PCT/US2008/003686 2007-03-20 2008-03-20 Methods and compositions for targeting afap WO2008133789A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08779575A EP2136620A2 (en) 2007-03-20 2008-03-20 Methods and compositions for targeting afap

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91908607P 2007-03-20 2007-03-20
US60/919,086 2007-03-20

Publications (3)

Publication Number Publication Date
WO2008133789A2 WO2008133789A2 (en) 2008-11-06
WO2008133789A3 true WO2008133789A3 (en) 2008-12-24
WO2008133789A4 WO2008133789A4 (en) 2009-02-19

Family

ID=39775374

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/003686 WO2008133789A2 (en) 2007-03-20 2008-03-20 Methods and compositions for targeting afap

Country Status (3)

Country Link
US (1) US20080234232A1 (en)
EP (1) EP2136620A2 (en)
WO (1) WO2008133789A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104443A1 (en) * 2001-09-21 2003-06-05 University Of West Virginia AFAP sequences, polypeptides, antibodies and methods
US7153843B2 (en) * 1998-06-26 2006-12-26 Georgetown University Inhibitors of phosphatidyl myo-inositol cycle

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612370A (en) * 1982-04-02 1986-09-16 The Regents Of The University Of California Lipid-saccharide reaction products
JPH0683633B2 (en) * 1987-04-08 1994-10-26 花王株式会社 Release oil composition for food
US5149794A (en) * 1990-11-01 1992-09-22 State Of Oregon Covalent lipid-drug conjugates for drug targeting
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153843B2 (en) * 1998-06-26 2006-12-26 Georgetown University Inhibitors of phosphatidyl myo-inositol cycle
US20030104443A1 (en) * 2001-09-21 2003-06-05 University Of West Virginia AFAP sequences, polypeptides, antibodies and methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAISDEN ET AL.: "The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity", ONCOGENE, vol. 20, 2001, pages 6435, XP008122478 *
RUCCI ET AL.: "Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy", J. PHARM. EXPT. THERAP., vol. 318, 2006, pages 161 - 172, XP008122477 *

Also Published As

Publication number Publication date
EP2136620A2 (en) 2009-12-30
WO2008133789A4 (en) 2009-02-19
WO2008133789A2 (en) 2008-11-06
US20080234232A1 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
AU2016204376A1 (en) MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer
WO2007123892A3 (en) Raf inhibitors and their uses
WO2009108860A8 (en) Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders
MX343042B (en) Bicyclic heteroaryl compounds.
WO2007053573A3 (en) Treatment of cancer with sorafenib
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
WO2011037643A3 (en) Compositions and methods for detecting and treating prostate carcinoma
WO2008128072A3 (en) Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
WO2009064486A3 (en) Inhibitors of pim protein kinases, compositions, and methods for treating cancer
MY184101A (en) Indoles
WO2010003520A3 (en) Anti-tumor immunotherapy
MX352892B (en) Yeast-muc1 immunotherapeutic compositions and uses thereof.
WO2010045345A3 (en) Treatment method
WO2009070294A3 (en) Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof
WO2008112290A3 (en) Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer
WO2008110379A3 (en) Monoclonal antibodies for treatment of cancer
AU2007249926A8 (en) Monocyclic heteroaryl compounds
UA99602C2 (en) Antibody that specifically binds to jam-a, capable of inhibiting the proliferation of tumor cells
NZ579478A (en) Epha3 antibodies for the treatment of solid tumors
WO2008061108A3 (en) Phthalazine derivatives
WO2013158373A8 (en) Indolin-2-one derivatives as protein kinase inhibitors
PH12020550476A1 (en) Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (cscs) by inhibiting mitochondrial respiration
MX2009010176A (en) 4-substituted azaadamantane derivatives and methods of use thereof.
WO2011021177A3 (en) Compositions and methods for prognosis and treatment of prostate cancer
WO2012078519A3 (en) 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08779575

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008779575

Country of ref document: EP

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)